Determination of Enantiomeric Purity of GSK962040 Based on Liquid Chromatography Using Chiral Stationary Phase Combined with a Pre-column Derivatization Procedure
暂无分享,去创建一个
[1] N. Nguyen,et al. The effect of camicinal (GSK962040), a motilin agonist, on gastric emptying and glucose absorption in feed-intolerant critically ill patients: a randomized, blinded, placebo-controlled, clinical trial , 2016, Critical Care.
[2] G. Sanger,et al. The pharmacodynamics, safety and pharmacokinetics of single doses of the motilin agonist, camicinal, in type 1 diabetes mellitus with slow gastric emptying , 2016, British journal of pharmacology.
[3] Xin Wang,et al. Determination of Repertaxin Enantiomeric Purity by HPLC on Chiral Stationary Phase , 2015, Chromatographia.
[4] R. Hobson,et al. The effects of camicinal, a novel motilin agonist, on gastro‐esophageal function in healthy humans—a randomized placebo controlled trial , 2015, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[5] Yongmei Xie,et al. Determination of the Enantiomeric Purity of Trelagliptin by Pre-Column Derivatization and Liquid Chromatography on a Chiral Stationary Phase , 2015, Chromatographia.
[6] Yinglan Zhao,et al. HPLC Determination of Enantiomeric Purity of PF-04136309 Based on a Chiral Stationary Phase , 2015, Chromatographia.
[7] B. Kuo,et al. The investigational drug camicinal for the treatment of gastroparesis , 2015, Expert opinion on investigational drugs.
[8] G. Sanger,et al. Drugs acting at 5‐HT4, D2, motilin, and ghrelin receptors differ markedly in how they affect neuromuscular functions in human isolated stomach , 2014, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[9] G. Sanger,et al. Ghrelin and motilin receptor agonists: time to introduce bias into drug design , 2014, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[10] G. Sanger,et al. Motilin: towards a new understanding of the gastrointestinal neuropharmacology and therapeutic use of motilin receptor agonists , 2013, British journal of pharmacology.
[11] G. Sanger,et al. Regional‐ and agonist‐dependent facilitation of human neurogastrointestinal functions by motilin receptor agonists , 2012, British journal of pharmacology.
[12] J. Tack,et al. Emerging drugs for functional dyspepsia , 2011, Expert opinion on emerging drugs.
[13] H. Nakajima,et al. Mechanism of interdigestive migrating motor complex in conscious dogs , 2010, Journal of Gastroenterology.
[14] Erik Näslund,et al. GSK962040: a small molecule, selective motilin receptor agonist, effective as a stimulant of human and rabbit gastrointestinal motility , 2009 .
[15] A. Muir,et al. Discovery of N-(3-fluorophenyl)-1-[(4-([(3S)-3-methyl-1-piperazinyl]methyl)phenyl)acetyl]-4-piperidinamine (GSK962040), the first small molecule motilin receptor agonist clinical candidate. , 2009, Journal of medicinal chemistry.
[16] L. Otterbein,et al. Development of potent, orally active 1-substituted-3,4-dihydro-2-quinolone glycogen phosphorylase inhibitors. , 2007, Bioorganic & medicinal chemistry letters.
[17] R. Nageswara Rao,et al. An improved and validated LC method for resolution of bicalutamide enantiomers using amylose tris-(3,5-dimethylphenylcarbamate) as a chiral stationary phase. , 2006, Journal of pharmaceutical and biomedical analysis.
[18] R. Cuomo,et al. Influence of Motilin on Gastric Fundus Tone and on Meal-Induced Satiety in Man: Role of Cholinergic Pathways , 2006, The American Journal of Gastroenterology.
[19] Y. Liu,et al. Chiral separation of enantiomers of amino acid derivatives by high-performance liquid chromatography on a norvancomycin-bonded chiral stationary phase. , 2004, Talanta.
[20] S. Olesik,et al. Chiral separation by simultaneous use of vancomycin as stationary phase chiral selector and chiral mobile phase additive. , 2000, Journal of chromatography. B, Biomedical sciences and applications.
[21] G. Hollingworth,et al. Developments and Advances in Gastrointestinal Prokinetic Agents , 2011 .